Activities of cethromycin and telithromycin against recent North American isolates of Streptococcus pneumoniae

被引:16
|
作者
Jorgensen, JH
Crawford, SA
McElmeel, ML
Whitney, CG
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Pathol, San Antonio, TX 78229 USA
[2] Ctr Dis Control & Prevent, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA USA
关键词
D O I
10.1128/AAC.48.2.605-607.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The in vitro activities of two investigational ketolides, cethromycin (formerly ABT-773) and telithromycin, were determined for a selected group of 312 Streptococcus pneumoniae isolates from a national surveillance program. The MIC of cethromycin at which 50% of the isolates were inhibited was 0.008 mug/ml, and the MIC at which 90% of the isolates were inhibited was 0.06 mug/ml; the corresponding values for telithromycin were less than or equal to0.015 and 0.25 mug/ml, respectively. For six quinupristin-dalfopristin-resistant strains, the cethromycin MICs were 0.25 to 16 mug/ml and the telithromycin MICs were 1 to 4 mug/ml. However, there was only 0.3% resistance to telithromycin.
引用
收藏
页码:605 / 607
页数:3
相关论文
共 50 条
  • [1] Activity of daptomycin against recent North American isolates of Streptococcus pneumoniae
    Restrepo, MI
    Velez, JA
    McElmeel, ML
    Whitney, CG
    Jorgensen, JH
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (09) : 2974 - 2977
  • [2] Comparative activities of the oxazolidinone AZD2563 and linezolid against selected recent north American isolates of Streptococcus pneumoniae
    Baum, SE
    Crawford, SA
    McElmeel, ML
    Whitney, CG
    Jorgensen, JH
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (09) : 3094 - 3095
  • [3] Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain:: in vitro activities of telithromycin and cethromycin
    Morosini, MI
    Cantón, R
    Loza, E
    del Campo, R
    Almaraz, F
    Baquero, F
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (01) : 50 - 55
  • [4] Streptococcus pneumoniae isolates resistant to telithromycin
    Rantala, M
    Haanpera-Heikkinen, M
    Lindgren, M
    Seppälä, H
    Huovinen, P
    Jalava, J
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (05) : 1855 - 1858
  • [5] Activities of telithromycin against 13,874 Streptococcus pneumoniae isolates collected between 1999 and 2003
    Farrell, DJ
    Felmingham, D
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (05) : 1882 - 1884
  • [6] In vitro antibacterial activities of doripenem, imipenem, and meropenem against recent Streptococcus pneumoniae isolates
    Baek, Jin Yang
    Ko, Kwan Soo
    Kang, Cheol-In
    Song, Jae-Hoon
    Peck, Kyong Ran
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2011, 71 (03) : 297 - 300
  • [7] In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms
    Morosini, MI
    Cantón, R
    Loza, E
    Negri, MC
    Galán, JC
    Almaraz, F
    Baquero, F
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (09) : 2427 - 2431
  • [8] Telithromycin-nonsusceptible clinical isolates of Streptococcus pneumoniae from Europe
    Al-Lahham, Adnan
    Appelbaum, Peter C.
    van der Linden, Mark
    Reinert, Ralf Rene
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (11) : 3897 - 3900
  • [9] In vitro efficacy of cefditoren against recent isolates of Streptococcus pneumoniae in Greece
    Poulakou, G.
    Katsarolis, I.
    Lianou, L.
    Labri, N.
    Hatzaki, D.
    Giamarellou, H.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S584 - S584
  • [10] In vitro activity of ketolides telithromycin and HMR 3004 against Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility
    Giovanetti, E
    Montanari, MP
    Marchetti, F
    Varaldo, PE
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (06) : 905 - 908